Patent Assignment
Reel/Frame 014340/0079
Assignment of Assignor's Interest
Recorded: 2004-02-13
Pages: 5
Assignors
QUAY, STEVEN C.
Executed: 2004-02-02
BRANDT, GORDON
Executed: 2004-02-02
KLEPPE, MARY S.
Executed: 2004-02-02
MACEVILLY, CONOR J.
Executed: 2004-02-02
Assignee
NASTECH PHARMACEUTICAL COMPANY INC.
3450 MONTE VILLA PARKWAY, LEGAL DEPARTMENT, BOTHELL, WASHINGTON, 98021-8906
Covered Property
(1)
Compositions and Methods for Enhanced Mucosal Delivery of Y2 Receptor-Binding Peptides and Methods for Treating and Preventing Obesity
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Feb 10, 2010
From: NASTECH PHARMACEUTICAL COMPANY INC.
To: MDRNA, INC.
Reel/Frame 023915/0694 →
Security Agreement (Patents)
Apr 28, 2010
From: MDRNA, INC. FKA NASTECH PHARMACEUTICAL COMPANY INC.
To: CEQUENT PHARMACEUTICALS, INC.
Reel/Frame 024300/0825 →
Release of Security Interest
Jul 30, 2010
From: CEQUENT PHARMACEUTICALS, INC.
To: MARINA BIOTECH, INC. (F/K/A MDRNA, INC.)
Reel/Frame 024767/0466 →
Security Agreement
Feb 15, 2012
From: MARINA BIOTECH, INC; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
To: GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
Reel/Frame 027712/0200 →
Release of Security Interest
Apr 14, 2014
From: GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
To: MARINA BIOTECH, INC.; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
Reel/Frame 032685/0158 →